These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1476 related items for PubMed ID: 19650569

  • 1. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study.
    Cortez-Dias N, Martins S, Belo A, Fiuza M, Investigadores do Estudo VALSIM.
    Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569
    [Abstract] [Full Text] [Related]

  • 2. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M, Cortez-Dias N, Martins S, Belo A, VALSIM study investigators.
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [Abstract] [Full Text] [Related]

  • 3. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

  • 4. Prevalence, management and control of diabetes mellitus and associated risk factors in primary health care in Portugal.
    Cortez-Dias N, Martins S, Belo A, Fiuza M, VALSIM.
    Rev Port Cardiol; 2010 Apr; 29(4):509-37. PubMed ID: 20734573
    [Abstract] [Full Text] [Related]

  • 5. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M, Umemura S.
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [Abstract] [Full Text] [Related]

  • 6. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
    Furtado C, Pinto M.
    Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
    [Abstract] [Full Text] [Related]

  • 7. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 8. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG, Yao XY, Tao QM, Zheng P, Chen JZ, Zhu JH, Zhang FR, Zheng LR, Zhao LL.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [Abstract] [Full Text] [Related]

  • 9. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the National Health and Nutrition Examination Survey 1999-2004.
    Gu Q, Burt VL, Paulose-Ram R, Dillon CF.
    Am J Hypertens; 2008 Jul; 21(7):789-98. PubMed ID: 18451806
    [Abstract] [Full Text] [Related]

  • 10. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM.
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
    Jassim al Khaja KA, Sequeira RP, Wahab AW, Mathur VS.
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
    [Abstract] [Full Text] [Related]

  • 12. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

  • 13. Patient satisfaction with antihypertensive therapy.
    Chen K, Chiou CF, Plauschinat CA, Frech F, Harper A, Dubois R.
    J Hum Hypertens; 2005 Oct; 19(10):793-9. PubMed ID: 15951740
    [Abstract] [Full Text] [Related]

  • 14. Uptake of angiotensin II receptor blockers in the treatment of hypertension.
    Greving JP, Denig P, van der Veen WJ, Beltman FW, Sturkenboom MC, de Zeeuw D, Haaijer-Ruskamp FM.
    Eur J Clin Pharmacol; 2005 Jul; 61(5-6):461-6. PubMed ID: 15912393
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E.
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive persistence and drug class.
    Marentette MA, Gerth WC, Billings DK, Zarnke KB.
    Can J Cardiol; 2002 Jun; 18(6):649-56. PubMed ID: 12107422
    [Abstract] [Full Text] [Related]

  • 18. [Prevalence, treatment and control of hypertension in family practice patients in France during 1994].
    Poggi L, Chamontin B, Lang T, Menard J, Chevalier H, Gallois H, Cremier O.
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1075-80. PubMed ID: 8949382
    [Abstract] [Full Text] [Related]

  • 19. Prevalence, awareness, treatment and control of hypertension in Portugal. The PAP study.
    De Macedo ME, Lima MJ, Silva AO, Alcântara P, Ramalhinho V, Carmona J.
    Rev Port Cardiol; 2007 Jan; 26(1):21-39. PubMed ID: 17427834
    [Abstract] [Full Text] [Related]

  • 20. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
    Boero R, Prodi E, Borsa S, Berti V, Fiorio E, Ferraro L, Massara C, Quarello F.
    G Ital Nefrol; 2002 Jan; 19(4):413-8. PubMed ID: 12369043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 74.